April 12 (Reuters) - Pulse Biosciences Inc:
* PULSE BIOSCIENCES ANNOUNCES POSITIVE RESULTS FROM ITS FIRST STUDY EVALUATING A CLINICAL TARGET AT MAJOR SCIENTIFIC MEETING
* AN INDEPENDENT, BLINDED PHOTOGRAPHIC REVIEW OF LESION IMAGES SCORED 71% OF LESIONS AS CLEAR OR MOSTLY CLEAR IN TRIAL
* PATIENTS RATED 78% OF LESION OUTCOMES AS SATISFIED OR MOSTLY SATISFIED, CLOSELY MIRRORING INVESTIGATOR RATINGS Source text for Eikon: Further company coverage:
